• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDINAL HEALTH 200, LLC RAPID ASSAY PIFA HEPARIN PLATELET FACT4; PLATELET FACTOR 4 RADIOIMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDINAL HEALTH 200, LLC RAPID ASSAY PIFA HEPARIN PLATELET FACT4; PLATELET FACTOR 4 RADIOIMMUNOASSAY Back to Search Results
Model Number 4036025A
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Insufficient Information (4580)
Event Date 09/17/2018
Event Type  Injury  
Manufacturer Narrative
Investigation into this reported incident is currently under investigation.A follow up report will be submitted by cardinal health.
 
Event Description
Plaintiff alleges that the ifu for the pifa test has specific storage conditions.Plaintiff further alleges that the cardinal health defendants were negligent in the transportation, shipping, storage and distribution of the pifa test including in failing to ensure the pifa tests were transported, shipped, stored, and distributed in accordance with the ifu; delivering pifa tests that had not been transported, shipped, stored, and distributed in accordance with the requirements in the ifu; failing to take reasonable measures to prevent affected pifa tests from being sold; failing to reasonably ensure that the pifa tests remained refrigerated throughout the distribution process; and failing to establish and maintain quality control to prevent defective shipping and distribution of the pifa tests.
 
Manufacturer Narrative
Product code 4036025a, rapid assay pifa heparin platelet fact4, manufactured by akers biosciences inc., manufacturer number 4036025, shipped to our cardinal health facility between 1/1/18 thru 8/30/2020.Upon receipt, products were removed from delivery trailers within the required timeframe per cardinal health policy and placed into refrigerated storage per labeled product storage conditions.Cardinal health shipped two orders to the hospital during this time.The products were packed in boxes with foam and the product is wrapped in plastic with ice on top and bottom per cardinal health policy and as directed by the manufacturer.As part of the shipping process, cardinal health stamps the paperwork with the time and date of packing and there is also a location for the customer to sign and note time of receipt.This stamp documents the amount of time the product is out of refrigerator and on ice.Cardinal health received no notification of this product being received past required time frame.There is no evidence of any temperature issue during this time with the product in question.No customer complaints have been received for a temperature issue on item 4036025a.There were no findings of any failures, therefore, the root cause could not be determined for this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAPID ASSAY PIFA HEPARIN PLATELET FACT4
Type of Device
PLATELET FACTOR 4 RADIOIMMUNOASSAY
Manufacturer (Section D)
CARDINAL HEALTH 200, LLC
3651 birchwood drive
waukegan IL 60085
MDR Report Key10691976
MDR Text Key211844495
Report Number1423537-2020-00545
Device Sequence Number1
Product Code LCO
UDI-Device Identifier00708872615123
UDI-Public00708872615123
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 11/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number4036025A
Device Catalogue Number4036025A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received09/21/2020
Patient Sequence Number1
Patient Outcome(s) Other;
-
-